RJA
IMPL

Raymond James & Associates’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History

Raymond James & Associates’s Portfolio IMPL Stock Details IMPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,500
Closed -$6.24K – 3920
2023
Q3 		$6.24K Hold
14,500
– – ﹤0.01% 3733
2023
Q2 		$18.4K Hold
14,500
– – ﹤0.01% 3721
2023
Q1 		$20.3K Hold
14,500
– – ﹤0.01% 3748
2022
Q4 		$54.4K Buy
+14,500
New +$54.4K ﹤0.01% 3656